Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary Syndrome
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Aug 1, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how often serious heart rhythm problems happen in patients who come to the emergency room with a certain type of heart condition called non-ST elevation acute coronary syndrome (NSTE-ACS). This condition is a type of heart attack or unstable chest pain that doesn’t show a specific pattern on an ECG test. While serious heart rhythm issues are well-known in other types of heart attacks, it’s unclear how often they occur in people with NSTE-ACS. The study aims to find out if these problems are rare enough that not every patient needs continuous heart monitoring in the emergency room.
Adults 18 years and older who are diagnosed with NSTE-ACS in the emergency room and can understand the study information may be eligible to participate. People with certain other heart conditions or serious illnesses won’t be included. If you join the study, doctors will monitor your heart rhythm during your hospital stay and collect information about your care and health outcomes for up to 30 days. This will help doctors better understand risks and improve care for people with this type of heart problem in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (≥ 18 years old) patient admitted to the emergency department
- • Able to understand the information provided
- • Diagnosis of non-ST segment elevation ACS established according to the lastest guidelines from the European Society of Cardiology and the 4th Universal Definition of myocardial infarction
- • No objection to participation in the study after receiving appropriate information
- Exclusion Criteria:
- • Patients subject to legal protection
- • Patient with cognitive impairment
- • Myocardial injury and/or symptoms attributable to Takotsubo syndrome, myocarditis, pericarditis, or acute heart failure
- • Clinical evidence suggestive of type 2 myocardial infarction, including acute anemia with hemoglobin \< 10 g/dL, sepsis, acute hypoxemic respiratory failure
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reims, Marne, France
Nancy, Meurthe Et Moselle, France
Haguenau, Bas Rhin, France
Strasbourg, Bas Rhin, France
Séléstat, Bas Rhin, France
Colmar, Haut Rhin, France
Mulhouse, Haut Rhin, France
Pont à Mousson, Meurthe Et Moselle, France
Toul, Meurthe Et Moselle, France
Poitiers, Vienne, France
Patients applied
Trial Officials
Sabrina GARNIER-KEPKA, Dr
Principal Investigator
Hôpitaux Universitaires de Strasbourg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported